Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB: KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce it's now being carried in 4 out of 7 western Whole Foods Market locations
Whole Foods Market, Inc. is an American multinational supermarketchain headquartered in Austin, Texas, which sells organic foods and products free from hydrogenated fats and artificial colors, flavors, and preservatives. Whole Foods seeks out the finest natural and organic foods available, maintains the strictest quality standards in the industry, and has an unshakeable commitment to sustainable agriculture. Whole Foods has more than 500 retail and non-retail locations in the US, Canada and the United Kingdom. It has 14 retail locations in Canada, of which 7 are in British Columbia, and 7 are in Ontario. In 2017, Amazon purchased Whole Foods Market for USD$13.7 Billion.
"Adding Whole Foods to our distribution network is a huge accomplishment for Komo and testament to the high quality of our products," says Komo CEO William White. "We are so pleased with the growth in the number of retail stores that are selling Komo products. We have to thank our sales broker, Cornerstone Sales, our distributors, and our dedicated team for this growth. We are very excited about continuing to share the love of plant-based foods through our wholesale expansion"
Komo can now be found on the shelves at Whole Foods Cambie, North Burnaby, Victoria, and North Vancouver.
Komo has a distribution network covering all provinces in Canada, including BRR Logistics, TransCold Distribution and Nationwide Natural Foods. Komo significantly scaled up its production capacity through a co-manufacturing arrangement late last year, setting up Komo for nationwide expansion. Komo is also available in select IGA, Fresh Market, as well as all Choices Markets, all Nesters Market locations, Fairway Markets and Nature's Fare locations. Komo is now also expanding to the United States.
Komo Plant Based Foods Inc. is a premium plant-based food company that develops, manufactures and sells a variety of plant-based frozen meals that are always hearty, satisfying, and made with wholesome ingredients. At Komo, our mission is to help make plant-based meals a staple on every dinner table by sharing our love for feel-good food that connects the people to the planet. We believe plant-based eating is the future and - Change can start with a single biteTM. Our experienced plant-based innovation and development team recreates vegan versions of traditionally cheesy and meaty classics, with 100% plants. Komo's products are sold direct-to-consumer through our eCommerce website and a distribution network of online and brick and mortar grocery, convenience and natural retailer channels. Our operating subsidiary Komo Comfort Foods launched in 2021 with our flagship products: plant-based Lasagna, Shepherd's Pie and Chickenless Pot Pie and has recently launched a new line - Komo Plant-Based Meal HelpersTM - versatile meal starters to allow the creation of many dishes at home. All of our products are 100% plant-based, made with wholesome ingredients, free from preservatives, and frozen for freshness. Freezing products is a natural and effective way of keeping food products for longer without having to use any preservatives. Komo's meals have a 1-year frozen shelf life. Komo also sells hot ready-to-eat meals in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc. will@komoeats.com 1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE: Komo Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
In 2021, the plant-based food market was worth an impressive US$7 billion, up 27 percent year over year and is expected to hit US$10.7 billion by 2027. We’ve also seen the rise of several new players in the industry since Beyond Meat’s (NASDAQ: BYND) IPO in 2019. Among these new companies is the Tattooed Chef (NASDAQ:TTCF) while more established food companies, like the Kellogg Company (NYSE:K) or Hormel Food (NYSE:HRL), have opted to create sub-brands that focus on plant-based products.
In Canada, the plant-based food industry is growing — sales of plant-based cheese alone in 2020 was valued at approximately US$12.1 million and is expected to reach US$23.9 million by 2026. To date, Canada has invested up to C$173 million in the Protein Industries through the country’s SuperCluster Initiative. This project aims to increase the value of key crops and serve growing markets in North America, Asia and Europe for plant-based or new food products. With the growing plant-based food industry in Canada supported by government funding, the opportunities for investors are bountiful.
Komo aims to take advantage of several prevailing consumer trends, including the blossoming plant-based revolution, the rise of the clean label consumer, and the reemergence of frozen foods. The company is working to make plant-based meals a staple on every dinner table through a strategy that focuses on making premium frozen meals a more accessible and flavorful experience through its innovative product catalog featuring meals/entrees, meal helpers, and sweets.
Komo Plant-Based Foods has a number of frozen comfort food products, including its shepherd’s pies, pot pies, and lasagna. Furthermore, the company has made several advances with respect to its means of revenue and distribution. On January 11, 2022 Komo teamed up with BRR Logistics, one of Canada’s largest frozen foods distributors, allowing them to source all of Komo’s frozen plant-based products in retail groups in Ontario and Quebec. This is supplemental to Komo Plant-Based Foods’ already impressive e-commerce revenue sources, its own website and Shopify, and through hot meal delivery apps including Uber Eats (NYSE:UBER) and Skip the Dishes, owned by Just Eats (NYSE:TKWY).
Komo Plant-Based Foods’ serving sizes give its customers the ability to share food with others in a convenient yet affordable package. The company also has access to three streams of revenue, namely retail distribution, e-commerce and hot meal delivery apps, making the company highly accessible to a wide variety of consumers. They currently have 120 distribution points across Canada, with plans to reach 550 by July 31, 2022. Recently, the company announced that its plant-based food products have become available for purchase in the United States.
The company’s leadership team has significant experience in the plant-based foods category. Komo Plant-Based Comfort Food CEO Jeffrey Ma has led innovation projects in plant-based nutrition and has extensive experience working for big brands, including Daiya Foods, VEGA and more. Meanwhile, Senior Director, Operations & Food Safety Adya Djoko has over 13 years of direct experience in the food industry. Director of Culinary Development Frédéric Gagné has worked as a plant-based chef for over 20 years.
The meals and entrees product line are designed to provide classic, hearty meals to vegans. It consists of filling, satisfying, favourites that appeal to a wide variety of demographics. Full entrees typically provide four-six servings, are designed for sharing and come in a ready-to-bake format.
The lasagna product offers vegans, and people aiming to reduce their meat consumption. a meat-free alternative. It consists of layers of semolina pasta, tomato lentil ragu, a chickpea béchamel sauce and a tofu ricotta-style spread. Available in both two-serving and five-six serving variations, the lasagna product is set to win the hearts of pasta lovers.
The shepherd’s pie is another attractive option for people looking for a tasty, meat alternative for dinner. The product consists of Yukon gold garlic mash, mushroom onion gravy, Canadian green lentils, and a veggie medley.
Meal helpers provide all the components a chef needs to simplify the plant-based cooking experience. This includes hearty classics, crowd favourites, and the staples required to add an infusion of flavour to any meal. Popular meal helpers include the bolognese sauce and taco filling.
The sweets product line is designed to provide vegans with access to classic dessert options. This category offers a variety of satisfying, indulgent, and comforting choices. Currently, the company offers vegan double chocolate oatmeal cookies within the sweets category.
William White founded the company in 2018 and as Chief Executive Officer, sets the corporate strategy for Komo, overseeing all capital raising activities and the company’s growth and ensuring that the company develops initiatives that can positively impact society, including issues affecting the environment and policies that support our workforce and diversity, engagement with the community and governance and oversight such as board composition, code and values. White was the Founder, President and CEO of Lynx Gold Corp (recently acquired by a public company). From November 2020 to the present, White has been the President and CEO of Komo Plant-Based Foods Inc. and led the acquisition of our operating subsidiary, Komo Plant-Based Comfort Foods Inc., where he previously served as President and Chief Executive Officer from January 2018 to December 2020.
Jeffrey Ma assumed the role of President and Chief Executive Officer of operating subsidiary Komo Plant-Based Comfort Foods Inc. on December 9, 2020. Under Ma’s leadership the initial product offering of Komo Comfort Foods through a proprietary eCommerce platform was launched. He has worked in the plant-based food industry for the past 9 years and his experience involves leading innovation platforms that include dairy-free alternatives, plant-based nutrition, and better-for-you snack formats. Ma was the Research and Development Project Lead at Daiya Foods Inc. for 4 years, team leader while the company grew to the #1 Plant-based cheese brand in North America. Ma was also the Research & Innovation Manager at Vancouver-based protein shake, snack bar and supplement maker VEGA (Danone Company) for three and a half years, team leader while the company grew to the #1 Plant-based Protein Powder brand in North America (acquired by Danone Co. in 2016).
Rick Huang has been CFO of the company since February 2021 and he manages the accounting and financial reporting for Komo Plant-Based Foods Inc. and subsidiaries. Huang has served as a CFO for publicly traded companies for more than a decade, managing all aspects of finance, banking, compliance, accounting, reporting, internal control, admin and supporting the board of directors in financial oversight. Previously, Huang served as CFO of Hanwei Energy Services Corp. (TSX:HE) from April 2007 to May 2018 where he has managed all aspects of finance, banking, compliance, accounting, reporting, internal control, admin and supporting the board of directors in financial oversight. He also has supervised all aspects of accounting for various subsidiary companies in Canada, China and Kazakhstan and consolidations under IFRS.
Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB:KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce it's now being carried in a total of 240 distribution points across Canada; 39 of which are in Eastern Canada
According to a 2020 Statista Report there are 2.3 million vegetarians in Canada and an additional 850,000 classified themselves as vegan. Research conducted by the Angus Reid Institute (Canadian non-profit independent research organization) has found that 1 in 5 Canadians (22%) who regularly eat meat would like to reduce the amount of meat they consume. In eastern Canada, which has a population of 14 million, people spend an average of $10,418 per year on food. Source: https://www.statista.com/statistics/567888/average-annual-household-expenditures-in-ontario-canada/
"We are so proud to have Komo Plant-Based frozen comfort foods distributed to the shelves in so many new communities allowing us to further our mission to make plant-based meals a staple on every dinner tables." Says CEO William White. "We delivered our first shipment of products to Ontario earlier this year and have since launched into 60 distribution points. Our retail partners understand our unique value proposition to deliver shareworthy plant-based meals grounded in real food and cooking that don't compromise on taste and experience."
Komo can now be found on the shelves at select Foodland, a Sobey's grocery banner, including Toronto Queens St., Danforth, Ave, Ayr, Clinton, Bell River, Brights Grove, Corunna, Dorchester, Hagersville, Dresden, Essex, Forest, Komoka, Port Stanley, Ridgetown, Thorold, Owen Sound, and Midland.
Komo has a distribution network covering all provinces in Canada, including BRR Logistics, TransCold Distribution and Nationwide Natural Foods. Komo significantly scaled up its production capacity through a co-manufacturing arrangement late last year, setting up Komo for nationwide expansion. Komo is also available in select Whole Foods Markets, IGA, Fresh Market, as well as all Choices Markets, all Nesters Market locations, Fairway Markets and Nature's Fare locations. Komo is now also expanding into the United States.
Komo Plant Based Foods Inc. is a premium plant-based food company that develops, manufactures and sells a variety of plant-based frozen meals that are always hearty, satisfying, and made with wholesome ingredients. At Komo, our mission is to help make plant-based meals a staple on every dinner table by sharing our love for feel-good food that connects the people to the planet. We believe plant-based eating is the future and - Change can start with a single biteTM. Our experienced plant-based innovation and development team recreates vegan versions of traditionally cheesy and meaty classics, with 100% plants. Komo's products are sold direct-to-consumer through our eCommerce website and a distribution network of online and brick and mortar grocery, convenience and natural retailer channels. Our operating subsidiary Komo Comfort Foods launched in 2021 with our flagship products: plant-based Lasagna, Shepherd's Pie and Chickenless Pot Pie and has recently launched a new line - Komo Plant-Based Meal HelpersTM - versatile meal starters to allow the creation of many dishes at home. All of our products are 100% plant-based, made with wholesome ingredients, free from preservatives, and frozen for freshness. Komo also sells hot ready-to-eat meals in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc.
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE: KOMO Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo" or the "Company") a premium plant-based food company, made its first in-person, U.S. trade show debut at Natural Products Expo West (NPEW), at the Anaheim Convention Center in Anaheim, California. At the conference, Komo took home the VegNews Best of Show Award 2022 for Best New Vegan Product of the show
Founded in 2000, VegNews is one of the most established vegan news sources in the world. It produces four magazines annually, reaching 3.6 million people monthly across print, digital, and social media.
"This was the first time that we showcased our Komo product lineup at an in-person U.S. trade show," said William White, CEO of Komo. "The response to our products was overwhelmingly positive, with our Plant-Based Lasagna even taking home a major prize at the conference."
Komo's Plant-Based Comfort Food Lineup Features:
"Participation in Expo West is a major stepping stone as we focus on growing our distribution network in the U.S. through retail, wholesale, and eCommerce channels," added White. "We believe that there is a significant gap in the plant-based food market that we are filling with our lineup of multi-serve plant-based meals. Eating plant-based should never feel like a trade-off, and doesn't have to be complicated."
The Plant-Based Food Association reported that sales of plant-based frozen meals reached $520 million in 2020, up 29% from 2019. And the American Frozen Food Institute's 2021 Power of Frozen Report detailed that 71% of consumers would like more frozen meals with increased levels of fruits and/or vegetables and 51% seek meatless entrées.
Natural Products Expo West has been running for over two decades and is the largest natural, organic, and healthy products trade show in North America, bringing together more than 3,600 companies and 86,000 industry professionals to showcase the entire value chain of healthy products, including today's best sellers and tomorrow trends.
Komo Plant Based Foods Inc. is a premium plant-based food company that believes plant-based eating is the future, and that change can start with a single bite™. The Company develops, manufactures and sells a variety of 100% plant-based, preservative-free, hearty, satisfying, and wholesome frozen meals under its operating subsidiary Komo Comfort Foods. The product line is focused on recreating vegan versions of traditionally cheesy and meaty comfort foods such as Lasagna, Shepherd's Pie, Chickenless Pot Pie, and a line of Plant-Based Meal HelpersTM. The Company's goal is to make plant-based meals a staple through feel-good food that connect people and planet. The products are sold direct-to-consumer via eCommerce, as well as in grocery, convenience, and natural retailers. The frozen meals have a 1-year shelf-life. Ready-to-eat meals are also available in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc.will@komoeats.com 1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE:Komo Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
The Company recorded over $100k in revenue for the month of February alone, which overshoots the Company's previous all-time high in December of 2021 by 46%
Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo" or the "Company") a premium plant-based food company, is pleased to announce that it's February revenue catapulted to over $100k, a full 46% increase over Komo's previous best month of sales in December 2021
"We are extremely proud of the momentum that the brand is gaining, and we have been focused not only on driving immediate sales, but also on laying the foundation for sustainable growth by strategic expansion of our distribution network, and customer-centric new product development," said William White, CEO of Komo. "We have an aggressive expansion strategy that we are implementing for the U.S. retail market, while also continuing to expand our distribution throughout Canada."
Since shipping its first pallet to the Quebec and Ontario markets at the beginning of this year, the brand is now available for sale throughout Quebec and Ontario in 40 locations, with agreements signed for 60 additional distribution points. This includes mainstream grocery stores such as Metro in Quebec, Sobey's franchises such as Foodland in Ontario, and specialty natural food retailers throughout Ontario including Ambrosia and Fiesta Farms.
Komo also delivered its first order to GTFO It's Vegan, a major plant-based eCommerce platform that is bringing Komo's products to consumers across the U.S.
"Just one year ago, we launched in our home market of Vancouver, and now we are serving customers across North America," added White. "Our customers are at the heart of everything we do, and their feedback is an essential component of our product development process. This focus on the customer has paid off, and in less than one year, we have received over 200 verified five-star buyer reviews online."
The Company's gross profit margin was at 35% during the most recently reported quarter ended October 31, 2021. The Company anticipates its gross margin to decrease slightly, but remain healthy as the Company focuses more resources on expansion efforts through wholesale channels, which deliver lower margins, but enable the company to earn greater market share and achieve other economies of scale.
Komo Plant Based Foods Inc. is a premium plant-based food company that believes plant-based eating is the future, and that change can start with a single bite™. The Company develops, manufactures and sells a variety of 100% plant-based, preservative-free, hearty, satisfying, and wholesome frozen meals under its operating subsidiary Komo Comfort Foods. The product line is focused on recreating vegan versions of traditionally cheesy and meaty comfort foods such as Lasagna, Shepherd's Pie, Chickenless Pot Pie, and a line of Plant-Based Meal HelpersTM. The Company's goal is to make plant-based meals a staple through feel-good food that connect people and planet. The products are sold direct-to-consumer via eCommerce, as well as in grocery, convenience, and natural retailers. The frozen meals have a 1-year shelf-life. Ready-to-eat meals are also available in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc.will@komoeats.com 1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE: Komo Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo" or the "Company") announces that its Plant-Based Lasagna has been named a finalist in the 2022 NEXTY Awards by Natural Products Expo West, in the category of Best New Frozen Product
The NEXTY Awards recognize the most progressive, innovative, inspiring and trustworthy products in the natural products industry in the United States. Finalists are chosen based on innovation, inspiration, integrity, and impact. A team of editors and trend researchers go through hundreds of nominees to select three finalists in each category. Other nominees in the frozen category include leading products from The Plant Based Seafood Co., Tattooed Chef, Alec's Ice Cream, Deep Indian Kitchen, and Tru Fru.
"This recognition comes at an exciting time for Komo as we build out our U.S. retail network," said William White, CEO of Komo. "There is growing demand for plant-based food from the U.S. and we are developing the right partnerships and strategies to satisfy this significant demand."
Winners will be announced in early March, prior to the Natural Products Expo West, which will take place at the Anaheim Convention Center from March 8-12, 2022. Komo will be attending the convention as part of its plan to expand U.S. distribution. Komo is already available for direct-to-consumer purchase across the U.S. through the eCommerce platform GTFO It's Vegan, and it's now focusing on building out U.S. retail distribution points.
Komo's Plant-Based Lasagna is hearty and wholesome, made with a rich tomato lentil ragu and creamy tofu ricotta, smothered between layers of semolina pasta, and topped with a "cheezy" chickpea bechamel sauce. Preservative-free and sold frozen for freshness, it is available in two sizes: a two-serving package (600g) and a full sized package with 5-6 servings (1.42kg).
"We are on a mission to change the way people eat, one family meal at a time, and make plant-based food a staple in everyone's diet," added White. "Our hearty comfort foods are delicious and satisfying, and packaged in Earth-friendly, recyclable aluminum with a recycled paperboard sleeve. The lasagna is good for both you and the planet. We are very proud of our team and honored to receive this recognition from NEXTY."
Komo Plant Based Foods Inc. is a premium plant-based food company that believes plant-based eating is the future, and that change can start with a single bite™. The Company develops, manufactures and sells a variety of 100% plant-based, preservative-free, hearty, satisfying, and wholesome frozen meals under its operating subsidiary Komo Comfort Foods. The product line is focused on recreating vegan versions of traditionally cheesy and meaty comfort foods such as Lasagna, Shepherd's Pie, Chickenless Pot Pie, and a line of Plant-Based Meal HelpersTM. The Company's goal is to make plant-based meals a staple through feel-good food that connect people and planet. The products are sold direct-to-consumer via eCommerce, as well as in grocery, convenience, and natural retailers. The frozen meals have a 1-year shelf-life. Ready-to-eat meals are also available in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc. will@komoeats.com 1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE:Komo Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo" or the "Company") announces closing of a non-brokered private placement financing with a total value of $1,080,252 at a price of $0.14 per unit (each, a "Unit"). Each Unit issued in the Placement consisted of one common share of the Company (each, a "Share") and one share purchase warrant (each, a "Warrant"), with each Warrant entitling the holder thereof to purchase one Share at a price of $0.20 per Share for a period of 24 months from the date of issuance
On February 11, 2022, the Company completed a private placement issuing 7,008,625 Units for gross proceeds of $981,208 (the "Placement") and the Company issued 707,458 Units on February 16, 2022 to convert an aggregate amount of $99,044 of debt owing to consultants of the Company (the "Debt Conversion"). The total amount of Units issued pursuant to the Placement and Debt Conversion is 7,716,110. $200,000 of the proceeds raised in the Placement were from a related party.
The Company paid finder's fees to an arm's length party that introduced the Company to subscribers participating in the Placement (the "Finder") equal to 8% cash and 8% finder's warrants with each finder's warrant exercisable into a Share at $0.14 per Share ("Finder's Warrants"). The Company paid Finder's Fees of $20,000 and issued 142,857 Finder's Warrants.
All securities issued in connection with the Placement are subject to a four-month and one day hold period in Canada from the date of the issuance of that security (the "Hold Period"). The securities are restricted from trading during the Hold Period.
The Company intends to use the net proceeds of the Placement for operations and expansion across Canada and the United States.
Komo Plant Based Foods Inc. is a premium plant-based food company that develops, manufactures and sells a variety of plant-based frozen meals that are always hearty, satisfying, and made with wholesome ingredients. At Komo, our mission is to help make plant-based meals a staple on every dinner table by sharing our love for feel-good food that connects the people to the planet. We believe plant-based eating is the future and - Change can start with a single biteTM. Our experienced plant-based innovation and development team recreates vegan versions of traditionally cheesy and meaty classics, with 100% plants. Komo's products are sold direct-to-consumer through our eCommerce website and a distribution network of online and brick and mortar grocery, convenience and natural retailer channels. Our operating subsidiary Komo Comfort Foods launched in 2021 with our flagship products: plant-based Lasagna, Shepherd's Pie and Chickenless Pot Pie and has recently launched a new line - Komo Plant - Based Meal HelpersTM - versatile meal starters to allow the creation of many dishes at home. All of our products are 100% plant-based, made with wholesome ingredients, free from preservatives, and frozen for freshness. Freezing products is a natural and effective way of keeping food products for longer without having to use any preservatives. Komo's meals have a 1-year frozen shelf life. Komo also sells ready-to-eat meals in Metro Vancouver through Uber Eats and Skip the Dishes.
Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods
For further information, please contact:
William White, President & CEO, Komo Plant Based Foods Inc. will@komoeats.com 1-866-969-0882
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forwardlooking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.
SOURCE:Komo Plant Based Foods Inc.
News Provided by ACCESSWIRE via QuoteMedia
- Levi & Korsinsky, LLP notifies investors in Aurinia Pharmaceuticals Inc. ("Aurinia Pharmaceuticals Inc." or the "Company") (NASDAQ: AUPH) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aurinia Pharmaceuticals Inc. investors who were adversely affected by alleged securities fraud between May 7, 2021 and February 25, 2022 . Follow the link below to get more information and be contacted by a member of our team:
https://www.zlk.com/pslra-1/aurinia-pharmaceuticals-inc-information-loss-submission-form?prid=26179&wire=4
AUPH investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia's 2022 sales outlook for the Company's only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Aurinia Pharmaceuticals Inc. during the relevant time frame, you have until June 14, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States .
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/auph-lawsuit-alert-levi--korsinsky-notifies-aurinia-pharmaceuticals-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-301529506.html
News Provided by PR Newswire via QuoteMedia
The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery
Grab Holdings Limited (NASDAQ:GRAB)
Investors Affected : November 12, 2021 - March 2, 2022
A class action has commenced on behalf of certain shareholders in Grab Holdings Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Grab's driver supply declined during the third quarter; (2) as a result, Grab continued to invest heavily in driver and consumer incentives to "preemptively recalibrate driver supply"; (3) as a result, the Company's financial results would be adversely impacted, including, among other things, a significant decline in revenue; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/grab-holdings-limited-loss-submission-form/?id=26201&from=1
Investors Affected : August 2, 2021 - March 28, 2022
A class action has commenced on behalf of certain shareholders in Volta Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Volta had improperly accounted for restricted stock units issued in connection with the business combination of Volta Industries, Inc. ("Legacy Volta") and Tortoise Acquisition Corp. II; (2) as a result, the Company had understated its net loss for third quarter 2021; (3) there were material weaknesses in the Company's internal control over financial reporting that resulted in a material error; (4) as a result of the foregoing, the Company would restate its financial statements; (5) as a result of the foregoing, Legacy Volta's founders would imminently exit the Company; (6) as a result, the Company's financial results would be adversely impacted; and (7) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/volta-inc-loss-submission-form/?id=26201&from=1
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Investors Affected : May 7, 2021 - February 25, 2022
A class action has commenced on behalf of certain shareholders in Aurinia Pharmaceuticals Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia's 2022 sales outlook for the Company's only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/aurinia-pharmaceuticals-inc-loss-submission-form/?id=26201&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: dg@securitiesclasslaw.com Phone: (212) 537-9430 Fax: (833) 862-7770
SOURCE: The Gross Law Firm
News Provided by ACCESSWIRE IA via QuoteMedia
The Class : Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) securities between May 7, 2021 and February 26, 2022, for violates of the Securities Exchange Act of 1934. Aurinia is a biopharmaceutical company that develops and commercializes therapies to treat diseases with unmet medical need in Japan and the People's Republic of China. The Company's only product is LUPKYNIS, which it offers for the treatment of adult patients with active lupus nephritis.
If you would like more information about Aurinia Pharmaceuticals Inc.'s misconduct, click here .
What is this Case About: Aurinia Pharmaceuticals Inc. Misstated the Financial Impact of its Drug LUPKYNIS
According to the complaint, throughout the class period, defendants failed to disclose that Aurinia was experiencing declining revenues and that the 2022 sales outlook for LYPKYNIS would fall short of expectations.
On February 28, 2022, Aurinia announced its financial results for the full quarter and full year ended December 31, 2021, including a year-over-year revenue decline and lower than expected sales outlook for 2022. On this news, Aurinia's stock fell $3.94 per share, or 24.26%, to close at $12.30 per share on February 28, 2022.
Next Steps: If you acquired shares of Aurinia Pharmaceuticals Inc. (AUPH) between May 7, 2021 and February 26, 2022, you have until June 14, 2022 , to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Contact us to learn more:
Aaron Dumas (800) 350-6003 adumas@robbinsllp.com Shareholder Information Form
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Aurinia Pharmaceuticals Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420006230/en/
Aaron Dumas Robbins LLP 5040 Shoreham Place San Diego, CA 92122 adumas@robbinsllp.com (800) 350-6003 www.robbinsllp.com
News Provided by Business Wire via QuoteMedia
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that the firm has filed a securities class action lawsuit against ABBVie, Inc. (ABBVie) (NYSE:ABBV) on behalf of all persons and entities who purchased or otherwise acquired ABBVie securities between April 30, 2021, and August 31, 2021, inclusive (the "Class Period
CLICK HERE TO SUBMIT YOUR ABBVIE LOSSES. YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/new-cases/abbvie-inc?utm_source=PR&utm_medium=link&utm_campaign=abbvie&mktm=r
CANNOT VIEW THIS VIDEO? PLEASE CLICK HERE
TO VIEW OUR COMPLAINT, PLEASE CLICK HERE
CLASS PERIOD: APRIL 30, 2021 through AUGUST 31, 2021
CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
James Maro, Esq. (484) 270-1453 or Email at info@ktmc.com
Kessler Topaz is one of the world's foremost advocates in protecting the public against corporate fraud and other wrongdoing. Our securities fraud litigators are regularly recognized as leaders in the field individually and our firm is both feared and respected among the defense bar and the insurance bar. We are proud to have recovered billions of dollars for our clients and the classes of shareholders we represent.
AbbVie is one of the world's largest pharmaceutical companies. The company's revenues will come under significant pressure in the coming years when its best-selling drug, Humira, will lose patent protection in 2023. Accordingly, AbbVie's future revenue and earnings depend in large part on its ability to develop new sources of revenue to offset Humira's lost sales. Rinvoq-an anti-inflammatory drug manufactured by AbbVie and used to treat rheumatoid arthritis (RA) and other diseases by inhibiting Janus kinase (JAK) enzymes-was touted as one such drug. Rinvoq was initially approved in the United States to treat only moderate to severe RA. However, AbbVie was actively pursuing additional treatment indications and, in 2020, asked the U.S. Food and Drug Administration (FDA) to approve Rinvoq for the treatment of several other diseases.
As is relevant here, Rinvoq is similar to other JAK inhibitor drugs, including Xeljanz, manufactured by Pfizer Inc. When the FDA approved Xeljanz in 2012 for the treatment of RA, it required an additional safety trial to evaluate Xeljanz's risk of triggering certain serious side effects. Beginning in February 2019, the FDA repeatedly warned the public that the safety trial indicated that Xeljanz's use could lead to serious heart-related issue, cancer, and other adverse events. Notwithstanding the similarities between Rinvoq and Xeljanz, during the Class Period, Defendants assured investors that Rinvoq was far safer than Xeljanz and not subject to the same regulatory risks.
However, investors began to learn the truth about Rinvoq's significant risks on June 25, 2021, when AbbVie revealed that the FDA was delaying its review of expanded treatment applications for Rinvoq due to the safety concerns associated with Xeljanz. On this news, the price of AbbVie common stock declined $1.76 per share, or approximately 1.5%, from a close of $114.74 per share on June 24, 2021, to close at $112.98 per share on June 25, 2021.
Then, on September 1, 2021, the FDA announced that final results from the Xeljanz safety trial established an increased risk of serious adverse events, even with low doses of Xeljanz. As a result, the FDA determined that it would require new and updated warnings for Xeljanz and Rinvoq because Rinvoq "share[s] similar mechanisms of action with Xeljanz" and "may have similar risks as seen in the Xeljanz safety trial." The FDA also indicated that it would further limit approved indications for Rinvoq as a result of these safety concerns. On this news, the price of AbbVie common stock declined $8.51 per share, or more than 7%, from a close of $120.78 per share on August 31, 2021, to close at $112.27 per share on September 1, 2021.
After the Class Period, on December 3, 2021, AbbVie announced that the FDA had updated Rinvoq's label to require additional safety warnings and limit marketing of Rinvoq to only its use after treatment with other drugs has failed. On January 11, 2022, Defendants admitted that these changes to Rinvoq's label would negatively impact sales, forcing the Company to reduce its long-term guidance for Rinvoq's sales in 2025.
The complaint alleges that, throughout the Class Period, the Defendants made materially false and/or misleading statements, about the company's business and operations. Specifically, Defendants misrepresented and/or failed to disclose that: (1) safety concerns about Xeljanz extended to Rinvoq and other JAK inhibitors; (2) as a result, it was likely that the FDA would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, Defendants' statements about the company's business, operations, and prospects lacked a reasonable basis, As a result of the Defendants' wrongful acts and omissions, and the significant decline in the market value of AbbVie's securities, AbbVie investors have suffered significant damages.
AbbVieinvestors may, no later than June 6, 2022, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLPor other counsel, or may choose to do nothing and remain an absent class member. Kessler Topaz Meltzer & Check, LLP encourages AbbVie investors who have suffered significant losses to contact the firm directly to acquire more information.
CLICK HERE TO SIGN UP FOR THE CASE
WHO CAN BE A LEAD PLAINTIFF?
A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
Kessler Topaz Meltzer & Check, LLP James Maro, Jr., Esq. 280 King of Prussia Road Radnor, PA 19087 (484) 270-1453 info@ktmc.com
SOURCE: Kessler Topaz Meltzer & Check, LLP
News Provided by ACCESSWIRE IA via QuoteMedia
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you
VRT Shareholders Click Here: https://www.zlk.com/pslra-1/vertiv-holdings-co-loss-submission-form?prid=26198&wire=1 IBM Shareholders Click Here: https://www.zlk.com/pslra-1/ibm-loss-submission-form?prid=26198&wire=1 AUPH Shareholders Click Here: https://www.zlk.com/pslra-1/aurinia-pharmaceuticals-inc-information-loss-submission-form?prid=26198&wire=1 * ADDITIONAL INFORMATION BELOW *
Vertiv Holdings Co (NYSE:VRT)
VRT Lawsuit on behalf of: investors who purchased April 28, 2021 - February 23, 2022 Lead Plaintiff Deadline : May 23, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vertiv-holdings-co-loss-submission-form?prid=26198&wire=1 According to the filed complaint, during the class period, Vertiv Holdings Co made materially false and/or misleading statements and/or failed to disclose that: (1) the Company could not adequately respond to supply chain issues and inflation by increasing its prices; (2) as a result of the increasing costs, Vertiv's earnings would be adversely impacted; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
International Business Machines Corporation (NYSE:IBM)
IBM Lawsuit on behalf of: investors who purchased April 4, 2017 - October 20, 2021 Lead Plaintiff Deadline: June 6, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ibm-loss-submission-form?prid=26198&wire=1 According to the filed complaint, during the class period, International Business Machines Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
AUPH Lawsuit on behalf of: investors who purchased May 7, 2021 - February 25, 2022 Lead Plaintiff Deadline: June 14, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/aurinia-pharmaceuticals-inc-information-loss-submission-form?prid=26198&wire=1 According to the filed complaint, during the class period, Aurinia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia's 2022 sales outlook for the Company's only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Eduard Korsinsky, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com
News Provided by ACCESSWIRE IA via QuoteMedia
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 14, 2022.
SO WHAT: If you purchased Aurinia Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Aurinia Pharmaceuticals class action, go to https://rosenlegal.com/submit-form/?case_id=3851 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 14, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Aurinia was experiencing declining revenues; (2) Aurinia's 2022 sales outlook for LUPKYNIS would fall well short of expectations; (3) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (4) as a result, the Company had overstated its financial position and/or prospects for 2022; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Aurinia Pharmaceuticals class action, go to https://rosenlegal.com/submit-form/?case_id=3851 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com cases@rosenlegal.com www.rosenlegal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/121023
News Provided by Newsfile via QuoteMedia
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.